Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review
When to stop or modify protocols Discontinue or modify protocols if symptoms worsen progressively, if new neurological symptoms develop, if allergic reactions occur, or if significant side effects emerge
Receptura je doplnna o koenzym Q10 (ubichinol), PQQ a vitamn B2 (riboflavin)
These ROS act as secondary messengers, activating the p38MAPK pathway, which is involved in the pathogenesis of APS (Feng et al., 2024)
Our study assessed only an acute hemodynamic effect of liraglutide and we did not see any significant changes of central aortic pressure
2,6 SGLT2i represent the first class of HF drugs targeting pathophysiological mechanisms different from neurohormonal activation and providing not only cardioprotective effects but also important metabolic benefits